当前位置:首页 - 行情中心 - 奥翔药业(603229) - 财务分析

奥翔药业

(603229)

  

流通市值:93.74亿  总市值:93.74亿
流通股本:8.30亿   总股本:8.30亿

奥翔药业(603229)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.69亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益242570.95万元,未分配利润104166.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产313506.11万元,负债70935.16万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入481,872,188.3306,636,220.57795,288,308.9690,126,439.62
营业总成本302,198,297.13169,849,438.7575,480,342.93436,562,072.07
其他经营收益
营业利润195,436,252.9136,769,869.82241,143,575.95261,919,470.22
利润总额194,677,453.13136,732,467.33240,200,048.65261,279,487.39
净利润169,346,106.65119,199,188.77206,791,017.22228,985,673.66
每股收益
其他综合收益9,445.84670,246.5329,582.577,367.73
综合收益总额169,355,552.49119,869,435.3206,820,599.79228,993,041.39
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,861,691,662.71,836,403,912.681,709,169,547.871,736,464,361.51
非流动资产:
非流动资产合计1,273,369,390.871,284,154,799.931,273,220,502.521,281,159,560.14
资产总计3,135,061,053.573,120,558,712.612,982,390,050.393,017,623,921.65
流动负债:
流动负债合计656,893,917.84714,430,201.79674,525,715.76686,271,542.48
非流动负债:
非流动负债合计52,457,685.0234,354,931.3335,973,131.9237,288,734.86
负债合计709,351,602.86748,785,133.12710,498,847.68723,560,277.34
所有者权益(或股东权益):
归属于母公司股东权益合计2,425,709,450.712,371,773,579.492,271,891,202.712,294,063,644.31
股东权益合计2,425,709,450.712,371,773,579.492,271,891,202.712,294,063,644.31
负债和股东权益合计3,135,061,053.573,120,558,712.612,982,390,050.393,017,623,921.65
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计436,663,112.49260,035,698.68853,563,748.87611,796,197.96
经营活动现金流出小计391,259,445.69257,989,311.38675,637,971.51527,892,685.96
经营活动产生的现金流量净额45,403,666.82,046,387.3177,925,777.3683,903,512
投资活动产生的现金流量:
投资活动现金流入小计39,477,425.085,947,942.7237,602,044.9411,517,089.34
投资活动现金流出小计67,801,763.7136,820,547.22157,570,981.9797,166,549.7
投资活动产生的现金流量净额-28,324,338.63-30,872,604.5-119,968,937.03-85,649,460.36
筹资活动产生的现金流量:
筹资活动现金流入小计246,589,792.7989,790,810.84290,812,726.52170,100,000
筹资活动现金流出小计242,733,760.37104,874,200.35399,032,612.08257,264,842.07
筹资活动产生的现金流量净额3,856,032.42-15,083,389.51-108,219,885.56-87,164,842.07
汇率变动对现金及现金等价物的影响5,776,044.163,875,717.8110,842,676.45-5,520,623.06
现金及现金等价物净增加额26,711,404.75-40,033,888.9-39,420,368.78-94,431,413.49
期末现金及现金等价物余额1,075,292,623.91,008,547,330.251,048,581,219.15993,570,174.44
补充资料:
现金及现金等价物的净增加额26,711,404.75--39,420,368.78-
最新报告期:2025-08-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫,乔露阳0.330.380.482025-08-28
TOP↑